Cargando…
Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
A 35-year-old female with pulmonary arterial hypertension (PAH) who presented with complaints of progressively worsening dysphagia, facial swelling, and shortness of breath, was found to have a large goiter. In patients treated with epoprostenol for long periods of time, thyroid disease is common. M...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998745/ https://www.ncbi.nlm.nih.gov/pubmed/32082680 http://dx.doi.org/10.1155/2020/1617253 |
_version_ | 1783493889874722816 |
---|---|
author | Abughazaleh, Shaadi Safdar, Zeenat |
author_facet | Abughazaleh, Shaadi Safdar, Zeenat |
author_sort | Abughazaleh, Shaadi |
collection | PubMed |
description | A 35-year-old female with pulmonary arterial hypertension (PAH) who presented with complaints of progressively worsening dysphagia, facial swelling, and shortness of breath, was found to have a large goiter. In patients treated with epoprostenol for long periods of time, thyroid disease is common. Most cases of thyroid disease describe thyrotoxicosis and hyperthyroid statues, but our case was a patient on long term IV epoprostenol presenting with a superior vena cava-syndrome (SVC) like appearance and airway compromise found to have a goiter incidentally during workup. |
format | Online Article Text |
id | pubmed-6998745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-69987452020-02-20 Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol Abughazaleh, Shaadi Safdar, Zeenat Case Rep Pulmonol Case Report A 35-year-old female with pulmonary arterial hypertension (PAH) who presented with complaints of progressively worsening dysphagia, facial swelling, and shortness of breath, was found to have a large goiter. In patients treated with epoprostenol for long periods of time, thyroid disease is common. Most cases of thyroid disease describe thyrotoxicosis and hyperthyroid statues, but our case was a patient on long term IV epoprostenol presenting with a superior vena cava-syndrome (SVC) like appearance and airway compromise found to have a goiter incidentally during workup. Hindawi 2020-01-23 /pmc/articles/PMC6998745/ /pubmed/32082680 http://dx.doi.org/10.1155/2020/1617253 Text en Copyright © 2020 Shaadi Abughazaleh and Zeenat Safdar. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Abughazaleh, Shaadi Safdar, Zeenat Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol |
title | Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol |
title_full | Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol |
title_fullStr | Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol |
title_full_unstemmed | Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol |
title_short | Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol |
title_sort | goiter in a patient with pulmonary arterial hypertension treated with epoprostenol |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998745/ https://www.ncbi.nlm.nih.gov/pubmed/32082680 http://dx.doi.org/10.1155/2020/1617253 |
work_keys_str_mv | AT abughazalehshaadi goiterinapatientwithpulmonaryarterialhypertensiontreatedwithepoprostenol AT safdarzeenat goiterinapatientwithpulmonaryarterialhypertensiontreatedwithepoprostenol |